相关实验视频

Updated: Feb 21, 2026

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

在治疗口腔关癌症的放射瘤学家中,实践模式的变化

Morgan Bailey¹, Jonathan Sackett, Hope Esslinger

¹Department of Radiation Oncology, University of Cincinnati, Cincinnati, OH.

American journal of clinical oncology

|February 19, 2026

概括

放射瘤学家在治疗HPV媒介口腔癌方面展示了多种方法,影响了临床试验设计和患者护理. 这凸显了在头部和部瘤学中需要标准化治疗方案的需要.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
头部和部癌症头部和部癌症

背景情况:

人类乳头瘤病毒 (HPV) 介导的口腔癌 (OPX) 的预后是有利的.
目前正在研究HPV+OPX的治疗降级策略.
了解当前的实践模式对于设计未来临床试验至关重要.

研究的目的:

调查专家头部和部 (H&N) 辐射瘤学家关于他们对OPX癌症治疗的实践模式.
为了识别HPV介导和HPV阴性OPX的辐射规划和治疗的变化.
为未来临床试验的设计提供信息,研究HPV+OPX治疗的缓解治疗.

主要方法:

一项调查分发给每年至少治疗12例非皮肤性H&N癌症的H&N辐射瘤学家.
该调查由25个问题组成,通过匿名RedCap链接进行管理.
结果使用RedCap统计数据和基平方 (χ2) 测试进行了分析.

主要成果:

55名H&N辐射瘤学家参加了会议,代表41个机构.
大多数医生给药的绝对辐射剂量为69.96或70 Gy.
对于HPV+OPX的CTV扩张 (平均3.6毫米) 和术后辐射剂量存在显著差异,化疗的指示不同.

结论:

在各机构对OPX癌症的辐射规划中存在相当大的差异和缺乏共识.
这种变化可能会对住院人员的培训和患者的结果产生负面影响.
需要对治疗方案进行标准化,以提高HPV+OPX管理的一致性和有效性.

关键词:

一致的共识共识.头部和部的头部和部.这是口腔喉癌.

更多相关视频

Learning Modern Laryngeal Surgery in a Dissection Laboratory

Learning Modern Laryngeal Surgery in a Dissection Laboratory

Published on: March 18, 2020

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...